Loading viewer...
conference
Format: PDF conference
Illumina presents its sequencing platforms, clinical genomics acceleration, and company overview at the 41st Annual J.P. Morgan Healthcare Conference. The presentation addresses the company's portfolio of instruments and consumables, including developments in cancer screening technology, while navigating regulatory challenges from the European Commission's prohibition of its GRAIL acquisition.
conference
31 Pages
conference
17 Pages
miRagen Therapeutics